BenzingaAugust 18, 2026 at 6:46 AM NY17 days ago

European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent Indication

Sanofi withdrew its Dupixent application for bullous pemphigoid on June 24, 2026, due to unresolved clinical trial limitations.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Companies in This Story